Belinda Shipman told Newsweek that the month-long treatment felt like her "face, body and mind were literally being torn apart." ...

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the ...

To improve chemotherapy dosing, engineers designed CLAUDIA, a way to continuously measure how much drug is in a patient's system during hours-long infusion. When cancer patients undergo chemotherapy, ...

A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors. Nivolumab (NIVO) plus ...

Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it. The Food and Drug Administration (FDA) has updated ...

US president Donald Trump has said that the Iran war is “close to over” and claimed Tehran wants to make a deal to end the conflict “very badly”. “If I pulled up stakes right now, it would take them ...

Consensus is rare — but when it comes to skin care, dermatologists agree: moisturizers, like sunscreen, are a critical component of any daily skin care routine. They not only prevent dryness and ...

UK cancer patients are facing mounting drug shortages as the Iran conflict disrupts global supply chains and pushes up medicine prices. Pharmacists warn that treatments and symptom‑management drugs ...